Mortality risk high among diabetes patients with prior CV events
Patients with Type 2 diabetes and acute coronary syndromes have a substantially increased risk of death in the 18 months after hospital admission for subsequent major nonfatal cardiovascular events, US researchers report. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Acute coronary syndromes Source Type: news
Liraglutide cardioprotective in high-risk Type 2 diabetes patients
Findings of the LEADER trial show that liraglutide treatment may confer a reduced risk of cardiovascular events in patients with Type 2 diabetes and a high vascular risk. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
Studies highlight ‘legacy’ effect of intensive diabetes interventions
Three studies published in Diabetes Care support the notion that even a temporary respite from the effects of Type 2 diabetes has long-term benefits for patients’ vascular health, with benefits reported for a range of interventions and outcomes. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
Right ventricular echocardiography predicts targeted therapy outcome in PAH
Echocardiography re-assessment of right ventricular function after targeted therapy is sufficient to predict subsequent prognosis in patients with pulmonary arterial hypertension, say researchers. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news
‘Hypertensive urgency’ may cause unnecessary alarm
Patients with a very high blood pressure reading in the absence of other symptoms are highly unlikely to have a major adverse cardiovascular event within the next 6 months, researchers report. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Hypertension Source Type: news
Age no barrier to vorapaxar use in ACS
The protease-activated receptor 1 inhibitor vorapaxar offers the same benefits to older and younger patients with non-ST segment elevation acute coronary syndromes, shows further analysis of the TRACER trial. (Source: MedWire News)
Source: MedWire News - June 14, 2016 Category: Consumer Health News Tags: Acute coronary syndromes Source Type: news
Combining decongestion markers may guide HF hospital discharge
Patients hospitalised with acute heart failure who achieve good haemoconcentration in addition to a robust diuretic response are unlikely to be rehospitalised within the following 2 months, research suggests. (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Heart failure Source Type: news
Individual patient meta-analysis supports tPA stroke benefits
The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists’ Collaboration. (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes
Research presented at the American Society of Clinical Oncology annual conference suggests that consolidation therapy with tandem compared with single myeloablative autologous stem cell transplant can improve outcomes in paediatric patients with high-risk neuroblastoma. (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Oncology Source Type: news
Liraglutide enhances high-dose insulin treatment in Type 2 diabetes
The addition of the glucagon-like peptide 1 receptor agonist liraglutide improves short-term outcomes and treatment satisfaction in patients who have uncontrolled Type 2 diabetes despite high doses of insulin, shows a randomised trial. (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
CRP may guide vascular risk assessment in obese
Low C-reactive protein levels may identify obese people who are unlikely to develop cardiovascular complications over subsequent years, show data from the EPIC study. (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Coronary heart disease Source Type: news
ATACH-2 disputes intensive BP control benefits in acute ICH
Reducing systolic blood pressure to less than 140 mmHg has offered no benefits over standard care for patients with acute intracerebral haemorrhage in the ATACH-2 trial. (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Immunoablation strengthens haemopoietic stem-cell transplantation effects in MS
Intensifying current transplant conditioning to remove rather than suppress immune cells ahead of autologous haematopoietic stem cell transplantation may result in long-term remission of multiple sclerosis, phase II trial findings show. (Source: MedWire News)
Source: MedWire News - June 10, 2016 Category: Consumer Health News Tags: Multiple sclerosis Source Type: news
Post PCI symmetry important for good clinical outcome
Postprocedural asymmetry following percutaneous coronary intervention is associated with an increased risk of adverse clinical outcome, particularly in patients with suboptimal expansion, researchers report. (Source: MedWire News)
Source: MedWire News - June 8, 2016 Category: Consumer Health News Tags: Interventional cardiology Source Type: news
Temporal hs-cTNT changes may predict future heart disease
Temporal increases in high-sensitivity cardiac troponin T are associated with a significantly increased risk of coronary heart disease, heart failure and death among people initially free from cardiovascular disease, US study data show. (Source: MedWire News)
Source: MedWire News - June 8, 2016 Category: Consumer Health News Tags: Coronary heart disease Source Type: news
